Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience
Conclusions: There are no definite correlations to the COVID-19 pandemic or vaccination and new or worsened otologic symptoms. Vaccinated patients with new or exacerbated otologic symptoms should be promptly referred for evaluation. Suspected cases of post-vaccination otologic symptoms should be reported to the Center for Disease Control (CDC) vaccine adverse event reporting system (VAERS).
This study aimed to understand the extent to which cannabis-related risk perception and COVID-19-related health worries were associated with the reported reduction in sharing cannabis smoking products to mitigate the risk of the coronavirus transmission or infection. This association was tested in two different periods in terms of toughness of national lockdown policy imposed in the first months of the pandemic in Israel. The study population included adult recreational cannabis users who completed one of the two online cross-sectional surveys dedicated to COVID-19 and the cannabis use situation in Israel in the first h...
“Last March, I was working in a small primary care practice on the west side of Denver. COVID-19 came to town. On Thursday, March 12, we were told the schools would be closing. On Friday, we were told that clinic staff had to wear masks — and the clinic had to start testing patients forRead more …I was thinking about retiring, and COVID-19 gave me a push [PODCAST] originally appeared inKevinMD.com.
OHSU's vaccination results are in line with other major Portland health systems.
The FDA has followed the advice of its advisory panels, approving additional doses of Moderna and J&J vaccines, and opening up people's options by letting them switch vaccine type for their booster.FDA Approvals
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
The U.S. Food and Drug Administration has given the O.K. to Covid-19 vaccine "booster" shots made by Cambridge biotech Moderna Inc. Moderna (Nasdaq: MRNA) is now able to make and distribute boosters — third shots identical to each of the first two in the series, but half the amount — for patients 65 and older, adults with underlying medical conditions and adults who are at a high risk for Covid-19 because of their occupati ons or time in institutional settings. The decision comes a few days…
The foundation has funded $1.9 billion in pandemic-related responses. Its latest pledge is to accelerate access for an experimental antiviral treatment for Covid-19 infections.
As the number of Americans getting COVID-19 vaccines has risen, there is a heightened push to provide booster shots to some vaccinated persons to ensure that their immunity continues.Medscape Reader Polls